Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × tosedostat × Clear all

NCT02352831 2019-08-28

Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Phase 1/2 Terminated

16 enrolled 15 charts

Gastrointestinal

Pancreatic Neoplasms